- The report contains detailed information about Advanced Viral Research Corp. that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
- Another part of the report is a SWOT-analysis carried out for Advanced Viral Research Corp.. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
- The Advanced Viral Research Corp. financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
- In the part that describes Advanced Viral Research Corp. competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
- Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of Advanced Viral Research Corp. business.
About Advanced Viral Research Corp.
Advanced Viral Research Corp., a biopharmaceutical company, focuses on the discovery, development and commercialization of small molecule therapeutics that address medical needs for various degenerative conditions.
The company develops its products focusing on the treatment of systemic symptoms, such as cachexia (body wasting), loss of appetite and lethargy experienced by patients with advanced malignant cancer, HIV-AIDS, cardiovascular disease, sepsis, viral infections, and other diseases, as well as to treat as an aid in wound healing. Its also develops its products for use as an anti-inflammatory in conditions, such as rheumatoid arthritis; and palliative agent to minimize certain toxicities associated with chemo or immunotherapies.
AVR118: The company's primary product, AVR118 is a cytoprotective drug composed of a mixture of protein and ribonucleic acid components that it is developing to alleviate symptoms associated with clinical cachexia, such as anorexia and weight loss, as well as other serious complications associated with cancer, HIV-AIDS, chronic heart failure, sepsis and other diseases.
AVR123: AVR123 is a form of AVR118 designed for dermatology applications. Based on early pre-clinical data, AVR123 may be used as an adjuvant therapy for the management of wounds and treatment of other dermal conditions. AVR123 is in Phase II clinical trials.
Other Compounds: AVR147, a compound acquired in December 2007, is a potent inhibitor of a validated cancer target known as a proteasome. Proteasomes are enzyme complexes that exist in all cells and play a role in degrading proteins involved in the cell cycle, growth of new blood vessels (angiogenesis), cell adhesion, cytokine production, apoptosis, and other cellular processes. The company is undertaking limited pre-clinical development of AVR147.
AVR168, a compound acquired in December 2007, is a natural product that inhibits a member of a family of motor proteins that are responsible for the assembly and function of microtubules during cell division. These proteins are important for intracellular transport and cell division in all eukaryotes. The company is undertaking limited pre-clinical development of AVR168.
The company identifies competition from Bristol-Myers Squibb; Serono Laboratories Inc.; Johnson & Johnson; Genentech, Inc.; and Smith and Nephew.
Advanced Viral Research Corp. was founded in 1984.
The above Company Fundamental Report is a half-ready report and contents are subject to change.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get all the most recent data available for the same price. Please note that preparation of additional types of analyses requires extra time.
1. ADVANCED VIRAL RESEARCH CORP. COMPANY PROFILE
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History
2. ADVANCED VIRAL RESEARCH CORP. BUSINESS OVERVIEW
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units
3. ADVANCED VIRAL RESEARCH CORP. SWOT ANALYSIS
4. ADVANCED VIRAL RESEARCH CORP. FINANCIAL ANALYSIS
4.1.1. Income Statement
4.1.2. Balance Sheet
4.1.3. Cash Flow
4.2. Financial Ratios
4.2.2. Margin Analysis
4.2.3. Asset Turnover
4.2.4. Credit Ratios
4.2.5. Long-Term Solvency
4.2.6. Growth Over Prior Year
4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot
5. ADVANCED VIRAL RESEARCH CORP. COMPETITORS AND INDUSTRY ANALYSIS
5.1. Advanced Viral Research Corp. Direct Competitors
5.2. Comparison of Advanced Viral Research Corp. and Direct Competitors Financial Ratios
5.3. Comparison of Advanced Viral Research Corp. and Direct Competitors Stock Charts
5.4. Advanced Viral Research Corp. Industry Analysis
5.4.1. Pharmaceuticals and Biotechnology Industry Snapshot
5.4.2. Advanced Viral Research Corp. Industry Position Analysis
6. ADVANCED VIRAL RESEARCH CORP. NEWS & EVENTS
6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events
7. ADVANCED VIRAL RESEARCH CORP. EXPERTS REVIEW1
7.1. Experts Opinion
7.2. Experts Estimates
8. ADVANCED VIRAL RESEARCH CORP. ENHANCED SWOT ANALYSIS2
9. UNITED STATES PESTEL ANALYSIS2
9.2. Economic Factors
9.3. Social Factors
9.4. Technological Factors
9.5. Environmental Factors
9.6. Legal Factors
10. ADVANCED VIRAL RESEARCH CORP. IFE, EFE, IE MATRICES2
10.2. External Factor Evaluation Matrix
10.3. Internal External Matrix
11. ADVANCED VIRAL RESEARCH CORP. PORTER FIVE FORCES ANALYSIS2
12. ADVANCED VIRAL RESEARCH CORP. VRIO ANALYSIS2
APPENDIX: RATIO DEFINITIONS
LIST OF TABLES
Advanced Viral Research Corp. Key Facts
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
Advanced Viral Research Corp. Key Executives
Key Executives Biographies1
Key Executives Compensations1
Advanced Viral Research Corp. Major Shareholders
Advanced Viral Research Corp. History
Advanced Viral Research Corp. Products
Revenues by Segment
Revenues by Region
Advanced Viral Research Corp. Offices and Representations
Advanced Viral Research Corp. SWOT Analysis
Yearly Income Statement Including Trends
Income Statement Latest 4 Quarters Including Trends
Yearly Balance Sheet Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Yearly Cash Flow Including Trends
Cash Flow Latest 4 Quarters Including Trends
Advanced Viral Research Corp. Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
Advanced Viral Research Corp. Capital Market Snapshot
Advanced Viral Research Corp. Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Pharmaceuticals and Biotechnology Industry Statistics
Advanced Viral Research Corp. Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
Advanced Viral Research Corp. Consensus Recommendations1
Analyst Recommendation Summary1
Price Target Summary1
Experts Recommendation Trends1
Revenue Estimates Analysis1
Earnings Estimates Analysis1
Revenue Estimates Trend1
Earnings Estimates Trend1
LIST OF FIGURES
Advanced Viral Research Corp. Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
Advanced Viral Research Corp. 1-year Stock Charts
Advanced Viral Research Corp. 5-year Stock Charts
Advanced Viral Research Corp. vs. Main Indexes 1-year Stock Chart
Advanced Viral Research Corp. vs. Direct Competitors 1-year Stock Charts
Advanced Viral Research Corp. Article Density Chart
2 – These sections are available only when you purchase a report with appropriate additional types of analyses.
The complete financial data is available for publicly traded companies.
Enhanced SWOT Analysis
- How to use the strengths to take advantage of the opportunities?
- How to use the strengths to reduce likelihood and impact of the threats?
- How to overcome the weaknesses that obstruct taking advantage of the opportunities?
- How to overcome the weaknesses that can make the threats a reality?
Key Factors Examined by PESTEL Analysis:
- Legal – What laws and legislation will exert influence on the style the business is carried out?
IFE, EFE, IE Matrices
Porter Five Forces Analysis
- What composes a threat of substitute products and services?
- Is there a threat of new competitors entering the market?
- What is the intensity of competitive rivalry?
- How big is the bargaining power of buyers?
- How significant is the bargaining power of suppliers?
- Tangible resources
- Intangible resources
- Innovation and Creativity
- Organizational capabilities
- Costly to imitate?
- Organized properly?